Inventor · disambiguated record
William Henry Miller
Also filed as: MILLER WILLIAM · MILLER WILLIAM H · MILLER WILLIAM HENRY
74 granted patents·13 pending applications·1,217 citations·filing 1991–2022
99Inventor score
Files withSMITHKLINE BEECHAM CORP21GLAXO GROUP LTD18AFFINIUM PHARM INC12GLAXOSMITHKLINE LLC8DU PONT MERCK PHARMA4
Top patents by PatentIndex Score
87 records- 0197US7250424B2Fab I inhibitorsAFFINIUM PHARM INC·Filed 2005·Granted Jul 31, 2007·36 cites·3 claims
- 0296US8536179B2IndolesMILLER WILLIAM H·Filed 2011·Granted Sep 17, 2013·47 cites·4 claims
- 0395US7741339B2Fab I inhibitorsAFFINIUM PHARM INC·Filed 2007·Granted Jun 22, 2010·15 cites·4 claims
- 0495US7524843B2Fab I inhibitorsAFFINIUM PHARM INC·Filed 2007·Granted Apr 28, 2009·28 cites·14 claims
- 0595US6730684B1Fab I inhibitorsAFFINIUM PHARM INC·Filed 2000·Granted May 4, 2004·47 cites·17 claims
- 0694US7205408B2Quinolines and nitrogenated derivative thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agentsSMITHKLINE BEECHAM PLC·Filed 2002·Granted Apr 17, 2007·48 cites·13 claims
- 0794US7049310B2Fab I inhibitorsAFFINIUM PHARM INC·Filed 2002·Granted May 23, 2006·35 cites·4 claims
- 0894US6762201B1Fab I inhibitorsAFFINIUM PHARM INC·Filed 2000·Granted Jul 13, 2004·39 cites·9 claims
- 0993US7790716B2Fab I inhibitorsAFFINIUM PHARM INC·Filed 2009·Granted Sep 7, 2010·19 cites·3 claims
- 1093US6846819B1Fab I inhibitorsAFFINIUM PHARM INC·Filed 2000·Granted Jan 25, 2005·40 cites·12 claims
- 1193US5563127ABoronic acid and ester inhibitors of thrombinDU PONT MERCK PHARMA·Filed 1994·Granted Oct 8, 1996·74 cites·7 claims
- 1292US6573272B1Antibacterial compoundsAFFINIUM PHARM INC·Filed 2000·Granted Jun 3, 2003·42 cites·4 claims
- 1392US6503903B1Fab I inhibitorsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Jan 7, 2003·41 cites·9 claims
- 1490US8765792B2IndolesKNIGHT STEVEN DAVID·Filed 2011·Granted Jul 1, 2014·8 cites·7 claims
- 1590US7691850B2Antibacterial agentsGLAXO GROUP LTD·Filed 2005·Granted Apr 6, 2010·9 cites·17 claims
- 1690US7557125B2Fab I inhibitorsAFFINIUM PHARM INC·Filed 2004·Granted Jul 7, 2009·28 cites·5 claims
- 1790US6765005B2Fab I inhibitorsAFFINIUM PHARM INC·Filed 2002·Granted Jul 20, 2004·33 cites·10 claims
- 1889US8975291B2IndolesGLAXOSMITHKLINE LLC·Filed 2013·Granted Mar 10, 2015·12 cites·5 claims
- 1988US9505745B2Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2014·Granted Nov 29, 2016·11 cites·20 claims
- 2088US8153652B2Fab I inhibitorsBURGESS WALTER J·Filed 2010·Granted Apr 10, 2012·9 cites·3 claims
- 2188US7648984B2Antibacterial agentsGLAXO GROUP LTD·Filed 2005·Granted Jan 19, 2010·13 cites·10 claims
- 2288US7605169B2Antibacterial agentsGLAXO GROUP LTD·Filed 2006·Granted Oct 20, 2009·6 cites·21 claims
- 2388US7109213B2Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing themGLAXO GROUP LTD·Filed 2003·Granted Sep 19, 2006·23 cites·16 claims
- 2488US5698538ABoronic acid and ester inhibitors of thrombinDU PONT MERCK PHARMA·Filed 1996·Granted Dec 16, 1997·42 cites·7 claims
- 2586US9346840B2Cyclopropylamines as LSD1 inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2014·Granted May 24, 2016·7 cites·12 claims
- 2686US9114141B2IndolesGLAXOSMITHKLINE LLC·Filed 2015·Granted Aug 25, 2015·4 cites·4 claims
- 2786US8846935B2IndazolesDUQUENNE CELINE·Filed 2011·Granted Sep 30, 2014·18 cites·7 claims
- 2886US8697685B2Chemical compoundsAXTEN JEFFREY MICHAEL·Filed 2009·Granted Apr 15, 2014·25 cites·8 claims
- 2986US7232832B2Antibacterial agentsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Jun 19, 2007·18 cites·11 claims
- 3086US5225418A5H-(1,2)benzisothiazolo[2,3-a]quinoline-5-ones and analogs as antiinflammatory agentsDU PONT MERCK PHARMA·Filed 1991·Granted Jul 6, 1993·29 cites·16 claims
- 3185US11919901B2Inhibitors of the menin-MLL interactionSYNDAX PHARMACEUTICALS INC·Filed 2022·Granted Mar 5, 2024·1 cites·28 claims
- 3285US8173646B2FAB I inhibitorsMILLER WILLIAM H·Filed 2010·Granted May 8, 2012·6 cites·8 claims
- 3385US6964970B2Antibacterial compoundsAFFINIUM PHARM INC·Filed 2003·Granted Nov 15, 2005·20 cites·20 claims
- 3485US6825188B2Vitronectin receptor antagonistsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Nov 30, 2004·14 cites·3 claims
- 3584US9073924B2AzaindazolesBURGESS JOELLE LORRAINE·Filed 2012·Granted Jul 7, 2015·5 cites·2 claims
- 3684US8637509B2AzaindazolesBURGESS JOELLE LORRAINE·Filed 2011·Granted Jan 28, 2014·12 cites·6 claims
- 3784US7592334B2Antibacterial agentsGLAXO GROUP LTD·Filed 2006·Granted Sep 22, 2009·4 cites·24 claims
- 3883US9382234B2Enhancer of Zeste Homolog 2 inhibitorsGLAXOSMITHKLINE LLC·Filed 2013·Granted Jul 5, 2016·8 cites·19 claims
- 3982US7648980B2Antibacterial agentsGLAXO GROUP LTD·Filed 2006·Granted Jan 19, 2010·3 cites·8 claims
- 4082US7608621B2N-substituted glycine derivatives: hydroxylase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2008·Granted Oct 27, 2009·6 cites·10 claims
- 4182US7312212B2Aminopiperidine derivativesGLAXO GROUP LTD·Filed 2003·Granted Dec 25, 2007·13 cites·14 claims
- 4281US9649307B2IndolesGLAXOSMITHKLINE LLC·Filed 2016·Granted May 16, 2017·2 cites·6 claims
- 4381US7759340B2Antibacterial agentsGLAXO GROUP LTD·Filed 2009·Granted Jul 20, 2010·2 cites·10 claims
- 4481US7498326B2CompoundsGLAXO GROUP LTD·Filed 2003·Granted Mar 3, 2009·12 cites·16 claims
- 4580US7511035B2Antibacterial agentsGLAXO GROUP LTD·Filed 2006·Granted Mar 31, 2009·2 cites·20 claims
- 4680US6069143AFibrinogen receptor antagonistsSMITHKLINE BEECHAM CORP·Filed 1996·Granted May 30, 2000·48 cites·6 claims
- 4779US9402836B2IndolesGLAXOSMITHKLINE LLC·Filed 2015·Granted Aug 2, 2016·2 cites·10 claims
- 4879US7709472B2Antibacterial agentsGLAXO GROUP LTD·Filed 2006·Granted May 4, 2010·3 cites·5 claims
- 4978US9790212B2Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2016·Granted Oct 17, 2017·2 cites·20 claims
- 5078US7655648B2Antibacterial agentsGLAXO GROUP LTD·Filed 2005·Granted Feb 2, 2010·3 cites·9 claims
Showing the top 50 of 87 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →